Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002440 · ClinicalTrials.gov registry record · NA
Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight
A NA study of Safety Issues and Efficacy, sponsored by University of California, San Diego.
- Active
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT04002440: Active NA study of Safety Issues and Efficacy, sponsored by University of California, San Diego.
NCT04002440 is a NA study of Safety Issues and Efficacy that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 28 participants, below the 118-participant average among 13 other Safety Issues trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04002440, a NA study of Safety Issues and Efficacy, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
Among ambulatory peritoneal dialysis patients, does use of the Baxter AMIA peritoneal dialysis cycler with SHARESOURCE connectivity platform achieve dry weight targets better than use of the Baxter Home Choice Pro cycler.
Primary Outcome
The investigators will evaluate the average difference between the actual dry weight vs. prescribed dry weight achieved through use of Baxter AMIA automated peritoneal dialysis system with SHARESOURCE connectivity compared to use of HomeChoicePRO.
Conditions Studied
Interventions
- COMBINATION_PRODUCT AMIA with SHARESOURCE Connectivity Platform
- DEVICE HomeChoice PRO
Study Locations (2)
California
- Home Dialysis Therapies of San Diego - Chula Vista
- Home Dialysis Therapies of San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-11-08 |
| Est. Completion | 2022-04 |
| Phase | NA |
What the registry record for NCT04002440 still lists
NCT04002440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 118-participant average among 13 other Safety Issues trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Safety Issues appearing as the primary indexed condition, and to 2 interventions - of which AMIA with SHARESOURCE Connectivity Platform is the first listed.
NCT04002440 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04002440 about?
NCT04002440 is a clinical study titled "Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight". Among ambulatory peritoneal dialysis patients, does use of the Baxter AMIA peritoneal dialysis cycler with SHARESOURCE connectivity platform achieve dry weight targets better than use of the Baxter Home Choice Pro cycler.
What is the current status of trial NCT04002440?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2018-11-08. Estimated completion is 2022-04.
What conditions does trial NCT04002440 study?
This clinical trial studies the following conditions: Safety Issues, Efficacy.
What interventions are being tested in trial NCT04002440?
The interventions under investigation include: AMIA with SHARESOURCE Connectivity Platform (COMBINATION_PRODUCT), HomeChoice PRO (DEVICE).
Who is sponsoring clinical trial NCT04002440?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04002440 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Safety Issues
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04002440's enrollment target sits among peer trials
28 8th of 13 higher than 6 of 13 other Safety Issues trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Safety Issues trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BeSMART Secure Storage Counseling in the Inpatient Setting
RECRUITING · NA
-
Effect of Naringenin and Beta Carotene on Energy Expenditure
COMPLETED · NA
-
Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults
COMPLETED · NA
-
Buck Institute Ketone Ester RCT
COMPLETED · NA
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI